deltatrials
Active Not Recruiting PHASE1 INTERVENTIONAL 1-arm NCT00911118

Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer

A Phase I Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer

Sponsor: Memorial Sloan Kettering Cancer Center

Conditions Adenocarcinoma Prostate Cancer
Interventions Hypofractionated, image-guided, intensity-modulated external beam radiation
Updated 20 times since 2017 Last updated: Jun 2, 2025 Started: May 31, 2009 Primary completion: May 31, 2026 Completion: May 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Adenocarcinoma and Prostate Cancer and is currently ongoing. Memorial Sloan Kettering Cancer Center leads this study, which shows 20 recorded versions since 2009 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshot~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Apr 2019 · 9 months · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jul 2019 · 2 months · monthly snapshot~Jul 2019 – ~Jul 2020 · 12 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Jul 2022 · 10 months · monthly snapshot~Jul 2022 – ~Jul 2023 · 12 months · monthly snapshot~Jul 2023 – ~Aug 2023 · 31 days · monthly snapshot~Aug 2023 – ~Oct 2023 · 2 months · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Jun 2025 · 8 months · monthly snapshot~Jun 2025 – ~Sep 2025 · 3 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

20 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting PHASE1

  2. Jun 2025 — Sep 2025 [monthly]

    Active Not Recruiting PHASE1

  3. Oct 2024 — Jun 2025 [monthly]

    Active Not Recruiting PHASE1

  4. Sep 2024 — Oct 2024 [monthly]

    Active Not Recruiting PHASE1

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE1

▶ Show 15 earlier versions

  1. Oct 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE1

  2. Aug 2023 — Oct 2023 [monthly]

    Active Not Recruiting PHASE1

  3. Jul 2023 — Aug 2023 [monthly]

    Active Not Recruiting PHASE1

  4. Jul 2022 — Jul 2023 [monthly]

    Active Not Recruiting PHASE1

  5. Sep 2021 — Jul 2022 [monthly]

    Active Not Recruiting PHASE1

  6. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE1

  7. Jul 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1

  8. Jul 2019 — Jul 2020 [monthly]

    Active Not Recruiting PHASE1

  9. May 2019 — Jul 2019 [monthly]

    Active Not Recruiting PHASE1

  10. Apr 2019 — May 2019 [monthly]

    Active Not Recruiting PHASE1

  11. Jul 2018 — Apr 2019 [monthly]

    Active Not Recruiting PHASE1

  12. Jun 2018 — Jul 2018 [monthly]

    Active Not Recruiting PHASE1

  13. Jun 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1

  14. Feb 2017 — Jun 2017 [monthly]

    Active Not Recruiting PHASE1

  15. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE1

    First recorded

May 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Memorial Sloan Kettering Cancer Center
  • Montefiore Medical Center
Data source: Memorial Sloan Kettering Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations